| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.75M | 21.96M | 29.95M | 43.09M | 39.24M | 29.19M |
| Gross Profit | 2.64M | 5.19M | 4.73M | 20.24M | 18.43M | 7.99M |
| EBITDA | -11.50M | -14.61M | -13.03M | 3.35M | 7.05M | -5.67M |
| Net Income | -11.97M | -14.36M | -19.58M | 2.37M | 12.81M | -6.16M |
Balance Sheet | ||||||
| Total Assets | 29.11M | 40.98M | 48.88M | 69.21M | 64.92M | 48.90M |
| Cash, Cash Equivalents and Short-Term Investments | 1.26M | 4.14M | 10.45M | 15.67M | 21.30M | 13.99M |
| Total Debt | 1.46M | 4.41M | 2.93M | 3.70M | 4.17M | 2.41M |
| Total Liabilities | 10.02M | 15.33M | 9.11M | 9.65M | 9.23M | 7.47M |
| Stockholders Equity | 19.09M | 25.65M | 39.77M | 59.56M | 55.69M | 41.44M |
Cash Flow | ||||||
| Free Cash Flow | -5.46M | -8.32M | -5.16M | -988.11K | 5.99M | -286.79K |
| Operating Cash Flow | -5.49M | -7.37M | -3.88M | 572.55K | 6.47M | 249.19K |
| Investing Cash Flow | -498.78K | -1.04M | -1.28M | -1.56M | -733.47K | -535.98K |
| Financing Cash Flow | -500.00K | 2.30M | -451.81K | 720.50K | 1.09M | 1.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $357.56M | 23.40 | 4.40% | 6.79% | 0.63% | -7.37% | |
64 Neutral | $3.75B | 27.58 | 8.24% | 1.46% | -0.40% | -68.99% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | $189.60M | -2.72 | -48.62% | ― | -12.89% | 45.32% | |
51 Neutral | $156.18M | -6.86 | -2.88% | 14.29% | 1.32% | -175.81% | |
46 Neutral | $19.79M | -2.25 | ― | ― | 4.49% | -87.94% | |
45 Neutral | $491.86K | -0.03 | -47.86% | ― | -33.51% | 36.29% |
On January 5, 2026, Charles & Colvard’s Board of Directors terminated President and Chief Executive Officer Don O’Connell without cause, marking a significant leadership change at the company. Effective the same day, Board Chair Michael Levin, 63, was appointed Executive Chair for an initial three-month term to oversee the company’s affairs, lead the executive team, and conduct the search for a new CEO, receiving $18,000 per month in lieu of other board compensation; the board emphasized Levin’s extensive financial and operational experience and clarified there are no family relationships, material related-party transactions, or special arrangements tied to his appointment.
The most recent analyst rating on (CTHR) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Charles & Colvard stock, see the CTHR Stock Forecast page.
On June 24, 2025, Charles & Colvard, Ltd. entered into a Convertible Secured Note Purchase Agreement with Ethara Capital LLC, issuing a convertible secured note for $2 million. However, on November 25, 2025, the company received a notice of default for failing to pay the principal and interest by the maturity date, leading to an increased interest rate and potential legal actions. The company is currently in litigation and discussions with the note holder. Additionally, on November 26, 2025, Neal Goldman resigned from the board of directors, and the company certified the results of its Annual Meeting of Shareholders, held on October 13, 2025, following a court injunction. Benjamin Franklin, Michael R. Levin, Duc Pham, and Lloyd M. Sems were elected to the board, with a tie creating a vacancy for the fifth seat.
The most recent analyst rating on (CTHR) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Charles & Colvard stock, see the CTHR Stock Forecast page.
Charles & Colvard, Ltd. held its Annual Meeting of Shareholders on October 13, 2025, focusing on the election of five board nominees. Due to ongoing legal challenges, the company has delayed announcing the meeting results, with plans to file an amended report once the situation is resolved.
The most recent analyst rating on (CTHR) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Charles & Colvard stock, see the CTHR Stock Forecast page.